 Your new post is loading...
A game-changing ruling may force drug companies to put patients, rather than profits at the heart of its business model writes Tim Smedley
Some of the initiatives pharmaceutical companies have employed in the name of corporate social responsibility
The world market for biosimilar drugs will reach a value of $2.44 billion for the whole of 2013, representing growth of more than 20% from 2012 and accounting for around 2% of the overall biological drugs market, according to a new study
The pharmaceutical industry has now entered the Outcomes Era where compounds must supply convincing evidence of a new drug’s value, with proof of the best possible health outcomes and additional benefits if it is to achieve attractive price and reimbursement levels, says new research
With cost-containment policies implemented in a large number of countries, the economic downturn has also had a large impact on the healthcare sector. To generate savings, cost-containment policies...
As the drug industry gets ready to invest more money into digital marketing to cut costs and increase efficiencies they have a lot of tactic available to them. Digital marketing, today, isn't just...
"The current R&D paradigm is bloated, duplicative, expensive, and in the long run, untenable," says GlobalData's Healthcare Industry Dynamics Team Analyst, Adam Dion . "There is a growing consensus in the industry that these challenges must be met collectively by bringing together public, private and government organizations to create multi-lateral collaborations to drive the next wave of scientific discovery."
For people who were blown away to learn recently that the 11 largest global pharmaceutical companies made an astonishing $711 billion in profits over the last decade, here's another measure of the industry's greed: The same companies paid their chief executive officers a combined $1.57 billion in that period.
Nearly six years ago, I, along with Dr. Jason Hwang and my mentor Clayton Christensen, founded Innosight Institute, a non-profit, nonpartisan think tank dedicated to improving the world through disruptive innovation.
Despite this competition, Pfizer believes that ertugliflozin may prove to be the best in class.
The costs and investment return for mobile health strategies vary depending on resource constraints, the number and types of offerings and their responsiveness to customers' needs.
Pharmas spent 40 more on nonpersonal promotion to healthcare professionals globally last year while continuing to shed sales reps, a Cegedim survey shows.
Harnessing the power of the digitally connected e-patient can not only help produce enormous amounts of savings in the health care system, but can also improve patient outcomes.
|
A new approach to negotiating price and contracts will be needed in the pharmaceuticals industry, a new report has said.
Novo Nordisk's chief executive Lars Rebien Sorensen has accused politicians in some European countries of making empty promises to their populations in terms of access to innovative drugs and called for more harmonisation of regulatory systems across the globe.
What are the criteria for the new commercial model of pharma?
The Challenge Facing payer pressure and the need to fill dry R&D pipelines, the pharmaceutical industry seeks new ways to redefine and increase its competitive edge.
/PRNewswire/ -- The global healthcare industry is in the middle of a massive remix, with disciplines merging and cross-pollinating. Technology continues to intrude into biology and society, as boundaries shift and disappear.
Pharma is awakening to the "New Normal" in customer engagement. And that's good news for all you digital marketers.
Sarah Boseley: The alliance between GlaxoSmithKline and Save the Children is a pragmatic one that will do good. But is it the best way forward?
International development charity Save the Children is linking up with British pharmaceutical giant GlaxoSmithKline in what both sides say is a unique collaboration to save children's lives in Africa.
One of the world’s largest pharmaceutical companies is trying something new. Starting this week, New York-based Pfizer will sell Viagra directly to consumers, so they don’t need to get it from a pharmacy.
Accenture survey reveals that digital, multichannel and analytics capabilities will be top strategic priorities for big pharma sales and marketing executives in 2013.
Which drugs were the biggest sellers last year? That’s what Genetic Engineering & Biotechnology News asked when compiling their Top 20 Best Selling Drugs
The negative public opinion that exists with regard to the pharmaceutical industry is sad and depressing. I personally experienced this negativity when I was on The Dr. Oz Show with industry critic, Dr.
|